Related Experiment Video
Updated: May 10, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Sex Differences in Clinical Outcomes Associated With Quantitative Flow Ratio-Guided Percutaneous
Yundai Chen1, Lei Gao2, Birgit Vogel3
1Department of Cardiology, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
Insights
Quantitative flow ratio (QFR)-guided percutaneous coronary intervention (PCI) improved outcomes for both men and women with coronary artery disease. QFR guidance demonstrated similar benefits across sexes, reducing major adverse cardiac events compared to standard angiography guidance.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Imaging
Background:
- The FAVOR III China trial showed improved outcomes with quantitative flow ratio (QFR)-guided percutaneous coronary intervention (PCI) over standard angiography guidance.
- However, the impact of QFR-guided PCI on clinical outcomes, specifically considering sex differences, remained unclear.
Purpose of the Study:
- To investigate potential sex-based differences in the 2-year clinical benefits of QFR-guided PCI.
- To compare outcomes between men and women undergoing contemporary PCI strategies.
Main Methods:
- A subgroup analysis of the FAVOR III China trial was conducted, randomizing participants to either QFR-guided or angiography-guided PCI.
- Major adverse cardiac events (MACE), including all-cause death, myocardial infarction, or ischemia-driven revascularization, were analyzed over 2 years.
- Sex differences in the efficacy of QFR guidance were assessed.
Main Results:
- The study included 1,126 women and 2,699 men, with similar 2-year MACE rates between sexes (10.3% vs 10.5%).
- QFR-guided PCI reduced PCI rates by 7.9% in men and 9.7% in women compared to angiography guidance.
- Both women (8.0% vs 12.7%) and men (8.7% vs 12.4%) experienced similar relative risk reductions in MACE with QFR guidance, with no significant interaction by sex (Pinteraction = 0.61).
Conclusions:
- QFR-guided PCI significantly improved 2-year MACE outcomes in both men and women compared to angiography-guided PCI.
- The clinical benefits of QFR-guided PCI were consistent across sexes, indicating its broad applicability in patients with coronary artery disease.
Background:
FAVOR III China (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease) reported improved clinical outcomes in quantitative flow ratio (QFR) relative to angiography-guided percutaneous coronary intervention (PCI), but the clinical impact of QFR-guided PCI according to sex remains unknown.
Objectives:
The authors sought to compare sex differences in the 2-year clinical benefits of a QFR-guided PCI strategy and to evaluate the differences in outcomes between men and women undergoing contemporary PCI.
Methods:
This study involved a prespecified subgroup analysis of the FAVOR III China trial, in which women and men were randomized to a QFR-guided strategy or a standard angiography-guided strategy. Sex differences in clinical benefit of the QFR guidance were analyzed for major adverse cardiac events (MACE), a composite of all-cause death, myocardial infarction, or ischemia-driven revascularization within 2 years.
Results:
A total of 1,126 women and 2,699 men were eligible and the occurrence of 2-year MACE was similar between women and men (10.3% vs 10.5%; P = 0.96). Compared with an angiography-guided strategy, a QFR-guided strategy resulted in a 7.9% and 9.7% reduction in PCI rates in men and women, respectively. A QFR-guided strategy resulted in similar relative risk reductions for 2-year MACE in women (8.0% vs 12.7%; HR: 0.62; 95% CI: 0.42-0.90) and men (8.7% vs 12.4%; HR: 0.69; 95% CI: 0.54-0.87) (Pinteraction = 0.61). Furthermore, QFR values were not significantly different between men and women with various angiographic stenosis categories.
Conclusions:
A QFR-guided PCI strategy resulted in improved MACE in both men and women at 2 years compared with an angiography-guided PCI strategy. The FAVOR III China Study [FAVOR III China]; (NCT03656848).
More Related Videos
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023